Vanda Pharmaceuticals Inc. financial data

Symbol
VNDA on Nasdaq
Industry
Pharmaceutical Preparations
Location
2200 Pennsylvania Ave Nw, Suite 300 E, Washington, District Of Columbia
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 550 % -2.1%
Quick Ratio 1.4 % -4.76%
Debt-to-equity 19 % -6.18%
Return On Equity -0.9 % -129%
Return On Assets -0.76 % -130%
Operating Margin -14.2 % -328%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58.2M shares +1.31%
Common Stock, Shares, Outstanding 58.2M shares +1.32%
Entity Public Float 369M USD -38.7%
Common Stock, Value, Issued 58K USD +1.75%
Weighted Average Number of Shares Outstanding, Basic 57.8M shares +1.32%
Weighted Average Number of Shares Outstanding, Diluted 57.8M shares +0.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 178M USD -30.8%
Revenue from Contract with Customer, Excluding Assessed Tax 178M USD -30.8%
Research and Development Expense 78.7M USD -6.3%
Costs and Expenses 203M USD -15.7%
Operating Income (Loss) -25.2M USD -257%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.85M USD -116%
Income Tax Expense (Benefit) 1.04M USD -87.7%
Net Income (Loss) Attributable to Parent -4.89M USD -131%
Earnings Per Share, Basic -0.09 USD/shares -132%
Earnings Per Share, Diluted -0.09 USD/shares -132%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 125M USD -64.7%
Accounts Receivable, after Allowance for Credit Loss, Current 36.7M USD +49.8%
Inventory, Net 1.51M USD +36.2%
Assets, Current 439M USD -17.7%
Deferred Income Tax Assets, Net 75.3M USD +5.01%
Property, Plant and Equipment, Net 2.31M USD -1.16%
Operating Lease, Right-of-Use Asset 6.74M USD -16.7%
Assets 653M USD +1.26%
Employee-related Liabilities, Current 2.38M USD -24.2%
Liabilities, Current 93.3M USD -0.48%
Operating Lease, Liability, Noncurrent 6.51M USD -22.3%
Other Liabilities, Noncurrent 8.83M USD +33.6%
Liabilities 109M USD -0.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -383K USD -50.2%
Retained Earnings (Accumulated Deficit) -160M USD -3.16%
Stockholders' Equity Attributable to Parent 544M USD +1.54%
Liabilities and Equity 653M USD +1.26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.57M USD -76.2%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -18.2M USD -110%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 58.2M shares +1.32%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.7M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 126M USD -64.6%
Deferred Tax Assets, Valuation Allowance 8.55M USD +19.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 85.9M USD +1.2%
Operating Lease, Liability 9.4M USD -15.6%
Depreciation 206K USD -29.2%
Payments to Acquire Property, Plant, and Equipment 7K USD -86.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.02M USD -129%
Lessee, Operating Lease, Liability, to be Paid 11.2M USD -19%
Property, Plant and Equipment, Gross 13.2M USD +1.74%
Operating Lease, Liability, Current 2.41M USD +2.73%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.8M USD +3.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.73M USD +2.99%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -246K USD -112%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.79M USD -33.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.41M USD -13.4%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -2.24M USD -281%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 18.3M USD +18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.16M USD -10.3%
Operating Lease, Payments 2.7M USD +3.85%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 2.45M USD -34%
Current Federal Tax Expense (Benefit) 2.58M USD
Amortization of Intangible Assets 3.73M USD +146%
Deferred Tax Assets, Net of Valuation Allowance 75M USD +1.3%
Share-based Payment Arrangement, Expense 13.3M USD -16.3%
Deferred State and Local Income Tax Expense (Benefit) 970K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%